Afanat (Afatinib), is a medication used to treat non-small cell lung carcinoma. It belongs to the tyrosine kinase inhibitor family of medications. It is mainly used to treat cases of NSCLC that harbour mutations in the epidermal growth factor receptor gene.
Title | Description |
---|---|
Dosage Form | Tablet |